KEYNOTE-164: Pembrolizumab for patients with advanced microsatellite instability high (MSI-H) colorectal cancer

Authors :: Chloe E. Atreya
Tong Dai
Patrick McKay Boland
Jean-Luc Van Laethem
Dung T. Le
Matthew Burge
Tae Won Kim
Hiroki Hara
Bert H. O'Neil
Eric Van Cutsem
Todd S. Crocenzi
L. Liang
Petr Kavan
Patricia Marinello
Hiroya Taniguchi
Luis A. Diaz
Manish R. Sharma
Ravit Geva
Source :: Journal of Clinical Oncology. 36:3514-3514
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: 3514Background: Pembrolizumab is approved for the treatment of adult and pediatric patients (pts) with previously treated MSI-H cancer regardless of tumor type or site. This approval was based in p...

Subjects :: 0301 basic medicine
Oncology
Cancer Research
medicine.medical_specialty
business.industry
Colorectal cancer
Cancer
Microsatellite instability
Pembrolizumab
medicine.disease
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
medicine
Tumor type
Previously treated
business

Full Text Access

Tools